APA

Alffenaar J. W. C., van der Laan T., Simons S., van der Werf T. S., van de Kasteele P. J., de Neeling H. & van Soolingen D. (20110601). Susceptibility of clinical Mycobacterium tuberculosis isolates to a potentially less toxic derivate of linezolid, PNU-100480. : Antimicrobial agents and chemotherapy.

Chicago

Alffenaar J W C, van der Laan T, Simons S, van der Werf T S, van de Kasteele P J, de Neeling H and van Soolingen D. 20110601. Susceptibility of clinical Mycobacterium tuberculosis isolates to a potentially less toxic derivate of linezolid, PNU-100480. : Antimicrobial agents and chemotherapy.

Harvard

Alffenaar J. W. C., van der Laan T., Simons S., van der Werf T. S., van de Kasteele P. J., de Neeling H. and van Soolingen D. (20110601). Susceptibility of clinical Mycobacterium tuberculosis isolates to a potentially less toxic derivate of linezolid, PNU-100480. : Antimicrobial agents and chemotherapy.

MLA

Alffenaar J W C, van der Laan T, Simons S, van der Werf T S, van de Kasteele P J, de Neeling H and van Soolingen D. Susceptibility of clinical Mycobacterium tuberculosis isolates to a potentially less toxic derivate of linezolid, PNU-100480. : Antimicrobial agents and chemotherapy. 20110601.